News
Certain proteins implicated in immune response and the body's process to stop bleeding may be biomarkers of BMD progression, ...
Insmed’s (INSM) treatment of Duchenne muscular dystrophy, the single-stranded, non-replicating, recombinant adeno-associated virus serotype 9 ...
4don MSNOpinion
Benefits outweigh risks. FDA right to greenlight Columbus company's treatment | Opinion
The FDA’s shift on Elevidys sends a message: boldness, scientific rigor and urgency are essential in confronting rare ...
WOOD Grand Rapids on MSN3d
‘Just gotta keep going’: Rockford honors man who died of Duchenne muscular dystrophy
The city of Rockford dedicated a memorial plaque to one of their own, who died in November to a form of muscular dystrophy.
Winning News Anchor Mike Bush Hosts 39th year of KSDK NBC’s “Show of Strength” live from Grants Farm in St. Louis on August ...
Echocardiography may be at the vanguard for early and rapid detection of heart issues indicative of Duchenne muscular ...
The first few months of 2025 brought hope to the rare disease community. Food and Drug Administration leadership promised ...
Keros Therapeutics, Inc. ('Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and ...
CureDuchenne, a global nonprofit based in Newport Beach that is dedicated to funding and finding a cure for Duchenne muscular ...
This weekend, the Rockford community will come together once again for the 27th Annual Mitchell's Run Thru Rockford (MRTR), a USATF-certified 5K run/walk and Kids K benefiting Parent Project Muscular ...
Zacks.com on MSN22h
RNA Stock Moves More Than 30% in a Week: What's Driving This Rally?
Avidity Biosciences surges 36% on reports that Novartis may eye a deal, with talks said to be early and interest from other suitors possible.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback